ATE544852T1 - Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie - Google Patents
Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenieInfo
- Publication number
- ATE544852T1 ATE544852T1 AT04770985T AT04770985T ATE544852T1 AT E544852 T1 ATE544852 T1 AT E544852T1 AT 04770985 T AT04770985 T AT 04770985T AT 04770985 T AT04770985 T AT 04770985T AT E544852 T1 ATE544852 T1 AT E544852T1
- Authority
- AT
- Austria
- Prior art keywords
- drug
- risk
- assessing
- induced granulocytopenia
- kit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003281937 | 2003-07-29 | ||
| PCT/JP2004/010722 WO2005010183A1 (ja) | 2003-07-29 | 2004-07-28 | 薬剤起因性顆粒球減少症発症リスク判定法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE544852T1 true ATE544852T1 (de) | 2012-02-15 |
Family
ID=34100975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04770985T ATE544852T1 (de) | 2003-07-29 | 2004-07-28 | Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US7790372B2 (de) |
| EP (2) | EP2275539B1 (de) |
| KR (2) | KR101176191B1 (de) |
| CN (1) | CN100482794C (de) |
| AT (1) | ATE544852T1 (de) |
| AU (1) | AU2004259952B2 (de) |
| CA (1) | CA2530168C (de) |
| ES (2) | ES2379811T3 (de) |
| TW (1) | TWI351436B (de) |
| WO (1) | WO2005010183A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090142766A1 (en) * | 2007-11-09 | 2009-06-04 | Washington University In St. Louis | Methods for measuring the metabolism of cns derived biomolecules in vivo |
| US20110177509A1 (en) * | 2008-07-23 | 2011-07-21 | The Washington University | Risk factors and a therapeutic target for neurodegenerative disorders |
| US20120289583A1 (en) * | 2009-12-31 | 2012-11-15 | Curna, Inc. | Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3) |
| JP6381919B2 (ja) * | 2014-01-24 | 2018-08-29 | 大塚製薬株式会社 | 化合物の無顆粒球症誘発性の評価方法 |
| EP3200832B1 (de) | 2014-09-30 | 2020-07-29 | Washington University | Kinetische tau-messungen |
| EP3938742A1 (de) | 2019-03-14 | 2022-01-19 | Terumo BCT Biotechnologies, LLC | Mehrteiliger lyophilisierungsbehälter und verwendungsverfahren |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| US5732076A (en) * | 1995-10-26 | 1998-03-24 | Omnipoint Corporation | Coexisting communication systems |
| EP2374890B1 (de) | 1996-11-29 | 2012-11-14 | Third Wave Technologies, Inc. | FEN-1-Endonucleasen, Mischungen und Spaltungsverfahren |
| US6159693A (en) | 1998-03-13 | 2000-12-12 | Promega Corporation | Nucleic acid detection |
| JP2000279197A (ja) | 1999-03-31 | 2000-10-10 | Genome Science Laboratories Co Ltd | Ｈｉｖの変異の検出方法 |
| US20030092019A1 (en) * | 2001-01-09 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
| US20030040315A1 (en) * | 2001-08-20 | 2003-02-27 | Farideh Khaleghi | Reduced state transition delay and signaling overhead for mobile station state transitions |
| US8958493B2 (en) * | 2004-03-31 | 2015-02-17 | Infineon Technologies Ag | Operation for backward-compatible transmission |
| US7764981B2 (en) * | 2004-07-30 | 2010-07-27 | Nokia Corporation | System and method for managing a wireless connection to reduce power consumption of a mobile terminal |
-
2004
- 2004-07-28 KR KR1020127013518A patent/KR101176191B1/ko not_active IP Right Cessation
- 2004-07-28 US US10/563,818 patent/US7790372B2/en not_active Expired - Fee Related
- 2004-07-28 CA CA2530168A patent/CA2530168C/en not_active Expired - Fee Related
- 2004-07-28 AT AT04770985T patent/ATE544852T1/de active
- 2004-07-28 EP EP10010352A patent/EP2275539B1/de not_active Not-in-force
- 2004-07-28 EP EP04770985A patent/EP1650300B1/de not_active Not-in-force
- 2004-07-28 ES ES04770985T patent/ES2379811T3/es active Active
- 2004-07-28 CN CNB2004800224990A patent/CN100482794C/zh not_active Expired - Fee Related
- 2004-07-28 AU AU2004259952A patent/AU2004259952B2/en not_active Ceased
- 2004-07-28 ES ES10010352T patent/ES2391076T3/es active Active
- 2004-07-28 WO PCT/JP2004/010722 patent/WO2005010183A1/ja active Application Filing
- 2004-07-29 TW TW093122778A patent/TWI351436B/zh not_active IP Right Cessation
-
2005
- 2005-12-19 KR KR1020057024365A patent/KR101176194B1/ko not_active IP Right Cessation
-
2010
- 2010-07-09 US US12/833,466 patent/US20100273175A1/en not_active Abandoned
- 2010-07-09 US US12/833,611 patent/US8492087B2/en not_active Expired - Fee Related
-
2013
- 2013-06-13 US US13/917,041 patent/US20140186826A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2275539A3 (de) | 2011-05-18 |
| CA2530168A1 (en) | 2005-02-03 |
| US7790372B2 (en) | 2010-09-07 |
| AU2004259952B2 (en) | 2008-10-16 |
| EP1650300A4 (de) | 2007-08-22 |
| EP1650300A1 (de) | 2006-04-26 |
| CN100482794C (zh) | 2009-04-29 |
| US8492087B2 (en) | 2013-07-23 |
| WO2005010183A1 (ja) | 2005-02-03 |
| CA2530168C (en) | 2014-05-27 |
| US20100273175A1 (en) | 2010-10-28 |
| TW200516152A (en) | 2005-05-16 |
| AU2004259952A1 (en) | 2005-02-03 |
| EP1650300B1 (de) | 2012-02-08 |
| EP2275539A2 (de) | 2011-01-19 |
| ES2379811T3 (es) | 2012-05-03 |
| US20100273176A1 (en) | 2010-10-28 |
| EP2275539B1 (de) | 2012-09-05 |
| KR101176194B1 (ko) | 2012-08-22 |
| KR101176191B1 (ko) | 2012-08-22 |
| ES2391076T3 (es) | 2012-11-21 |
| KR20120068995A (ko) | 2012-06-27 |
| CN1833023A (zh) | 2006-09-13 |
| KR20060040600A (ko) | 2006-05-10 |
| US20140186826A1 (en) | 2014-07-03 |
| US20070264631A1 (en) | 2007-11-15 |
| TWI351436B (en) | 2011-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005035545A3 (en) | Single nucleotide polymorphism analysis of highly polymorphic target sequences | |
| DE602004015408D1 (de) | Verfahren zur analyse von polymer-populationen | |
| DE602004019941D1 (de) | Verfahren für multiplex-polymerasekettenreaktionen auf hohem niveau und homogenen massenverlängerungsreaktionen zur genotypisierung von polymorphismen | |
| ATE534753T1 (de) | Zusammensetzungen und verfahren zur identifikation eines carbapenemase-gens | |
| WO2007134235A3 (en) | Hla alleles associated with adverse drug reactions and methods for detecting such | |
| DK1730315T3 (da) | Polymorphismer i NOD2/Card15 gen | |
| EP3318643A3 (de) | Verfahren und zusammensetzungen zur identifizierung und behandlung von lupus | |
| ATE544852T1 (de) | Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie | |
| ATE474067T1 (de) | Verfahren zur ermittlung von arzneimittelempfindlichkeit durch analyse von girk-kanal-genen | |
| DK1791973T3 (da) | DOT1-histonmethyltransferaser som et target til at identificere terapeutiske midler mod leukæmi | |
| WO2005112568A3 (en) | Haplotype markers and methods of using the same to determine response to treatment | |
| EP1767653A4 (de) | Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde | |
| ATE554164T1 (de) | Primer für nukleinsäureamplifikation bei der detektion von haushaltsgen-mrna und testverfahren unter verwendung der primer | |
| DE602004030910D1 (de) | Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen | |
| DE69710469D1 (de) | Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus | |
| ATE463562T1 (de) | Lp-pla2-aktivitätstest mit hohem durchsatz | |
| ATE555197T1 (de) | Verfahren zur evaluierung der wirkstoffsensitivität mittels analyse des pomc- gens | |
| ATE541058T1 (de) | Verfahren zum nachweis von wurzelknöllchen- nematoden | |
| DE60324819D1 (de) | Verfahren zur amplifikation von nukleinsäure, kit zur amplifikation von nukleinsäure, verfahren zum nachweis von einzelnukleotid-polymorphismus und reagentienkit zum nachweis von einzelnukleotid-polymorphismus | |
| ATE432996T1 (de) | Verfahren zur bestimmung des bodenzustands | |
| MX2007012170A (es) | Polimorfismos del gen de la enfermedad c1 tipo de nieman pick (npc1l1), y metodos de uso de los mismos. | |
| DE60235581D1 (de) | Testverfahren für lebensmittel | |
| DE602004019067D1 (de) | Verfahren zum nachweis des gens einer beta-3-adrenalinrezeptor-mutante sowie nukleinsäuresonde und kit dafür | |
| ATE513061T1 (de) | Diagnostisches verfahren und kit zur bestimmung des kell-blutgruppengenotyps | |
| DE60334132D1 (de) | Neues verfahren zum testen von nukleinsäure unter verwendung von markiertem nukleotid |